Rat And Mouse Model Market (By Type: Knockout, Knock-in, Outbred, Inbred; By Technology: Nuclear transferase, Microinjection, Embryonic stem cells, CRISPR/Cas9; By Service: Cryopreservation, Breeding, Rederivation, Genetic testing, Quarantine depending; By Application: Cardiovascular diseases, Genetic diseases, Cancer, Infectious diseases, Transplantation, Toxicology studies; By End-use: Pharmaceutical companies, Academic and research facilities, Biotechnology companies, Contract research & manufacturing organizations) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Rat And Mouse Model Market, By Type

7.1.  Rat And Mouse Model Market, by Type, 2021-2030

7.1.1.    Knockout

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Knock-in

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Outbred

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Inbred

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Rat And Mouse Model Market, By Technology

8.1.  Rat And Mouse Model Market, by Technology, 2021-2030

8.1.1.    Nuclear transferase

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Microinjection

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Embryonic stem cells

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    CRISPR/Cas9

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Rat And Mouse Model Market, By Service

9.1.  Rat And Mouse Model Market, by Service, 2021-2030

9.1.1.    Cryopreservation

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Breeding

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Rederivation

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Genetic testing

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Quarantine depending

9.1.5.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Rat And Mouse Model Market, By Application

10.1.        Rat And Mouse Model Market, by Application, 2021-2030

10.1.1.  Cardiovascular diseases

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Genetic diseases

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Cancer

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Infectious diseases

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Transplantation

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Toxicology studies

10.1.6.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Rat And Mouse Model Market, By End-use

11.1.        Rat And Mouse Model Market, by End-use, 2021-2030

11.1.1.  Pharmaceutical companies

11.1.1.1.      Market Revenue and Forecast (2017-2030)

11.1.2.  Academic and research facilities

11.1.2.1.      Market Revenue and Forecast (2017-2030)

11.1.3.  Biotechnology companies

11.1.3.1.      Market Revenue and Forecast (2017-2030)

11.1.4.  Contract research & manufacturing organizations

11.1.4.1.      Market Revenue and Forecast (2017-2030)

Chapter 12.      Global Rat And Mouse Model  Market, Regional Estimates and Trend Forecast

12.1.        North America

12.1.1.  Market Revenue and Forecast, by Type (2017-2030)

12.1.2.  Market Revenue and Forecast, by Technology (2017-2030)

12.1.3.  Market Revenue and Forecast, by Service (2017-2030)

12.1.4.  Market Revenue and Forecast, by Application (2017-2030)

12.1.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.1.6.  U.S.

12.1.6.1.      Market Revenue and Forecast, by Type (2017-2030)

12.1.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3.      Market Revenue and Forecast, by Service (2017-2030)

12.1.6.4.      Market Revenue and Forecast, by Application (2017-2030)

12.1.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.1.7.  Rest of North America

12.1.7.1.      Market Revenue and Forecast, by Type (2017-2030)

12.1.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.1.7.3.      Market Revenue and Forecast, by Service (2017-2030)

12.1.7.4.      Market Revenue and Forecast, by Application (2017-2030)

12.1.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.        Europe

12.2.1.  Market Revenue and Forecast, by Type (2017-2030)

12.2.2.  Market Revenue and Forecast, by Technology (2017-2030)

12.2.3.  Market Revenue and Forecast, by Service (2017-2030)

12.2.4.  Market Revenue and Forecast, by Application (2017-2030)

12.2.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.2.6.  UK

12.2.6.1.      Market Revenue and Forecast, by Type (2017-2030)

12.2.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3.      Market Revenue and Forecast, by Service (2017-2030)

12.2.6.4.      Market Revenue and Forecast, by Application (2017-2030)

12.2.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.7.  Germany

12.2.7.1.      Market Revenue and Forecast, by Type (2017-2030)

12.2.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3.      Market Revenue and Forecast, by Service (2017-2030)

12.2.7.4.      Market Revenue and Forecast, by Application (2017-2030)

12.2.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.8.  France

12.2.8.1.      Market Revenue and Forecast, by Type (2017-2030)

12.2.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3.      Market Revenue and Forecast, by Service (2017-2030)

12.2.8.4.      Market Revenue and Forecast, by Application (2017-2030)

12.2.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.2.9.  Rest of Europe

12.2.9.1.      Market Revenue and Forecast, by Type (2017-2030)

12.2.9.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.2.9.3.      Market Revenue and Forecast, by Service (2017-2030)

12.2.9.4.      Market Revenue and Forecast, by Application (2017-2030)

12.2.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.        APAC

12.3.1.  Market Revenue and Forecast, by Type (2017-2030)

12.3.2.  Market Revenue and Forecast, by Technology (2017-2030)

12.3.3.  Market Revenue and Forecast, by Service (2017-2030)

12.3.4.  Market Revenue and Forecast, by Application (2017-2030)

12.3.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.3.6.  India

12.3.6.1.      Market Revenue and Forecast, by Type (2017-2030)

12.3.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3.      Market Revenue and Forecast, by Service (2017-2030)

12.3.6.4.      Market Revenue and Forecast, by Application (2017-2030)

12.3.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.7.  China

12.3.7.1.      Market Revenue and Forecast, by Type (2017-2030)

12.3.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3.      Market Revenue and Forecast, by Service (2017-2030)

12.3.7.4.      Market Revenue and Forecast, by Application (2017-2030)

12.3.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.8.  Japan

12.3.8.1.      Market Revenue and Forecast, by Type (2017-2030)

12.3.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3.      Market Revenue and Forecast, by Service (2017-2030)

12.3.8.4.      Market Revenue and Forecast, by Application (2017-2030)

12.3.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.3.9.  Rest of APAC

12.3.9.1.      Market Revenue and Forecast, by Type (2017-2030)

12.3.9.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.3.9.3.      Market Revenue and Forecast, by Service (2017-2030)

12.3.9.4.      Market Revenue and Forecast, by Application (2017-2030)

12.3.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.        MEA

12.4.1.  Market Revenue and Forecast, by Type (2017-2030)

12.4.2.  Market Revenue and Forecast, by Technology (2017-2030)

12.4.3.  Market Revenue and Forecast, by Service (2017-2030)

12.4.4.  Market Revenue and Forecast, by Application (2017-2030)

12.4.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.4.6.  GCC

12.4.6.1.      Market Revenue and Forecast, by Type (2017-2030)

12.4.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3.      Market Revenue and Forecast, by Service (2017-2030)

12.4.6.4.      Market Revenue and Forecast, by Application (2017-2030)

12.4.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.7.  North Africa

12.4.7.1.      Market Revenue and Forecast, by Type (2017-2030)

12.4.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3.      Market Revenue and Forecast, by Service (2017-2030)

12.4.7.4.      Market Revenue and Forecast, by Application (2017-2030)

12.4.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.8.  South Africa

12.4.8.1.      Market Revenue and Forecast, by Type (2017-2030)

12.4.8.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3.      Market Revenue and Forecast, by Service (2017-2030)

12.4.8.4.      Market Revenue and Forecast, by Application (2017-2030)

12.4.8.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.4.9.  Rest of MEA

12.4.9.1.      Market Revenue and Forecast, by Type (2017-2030)

12.4.9.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.4.9.3.      Market Revenue and Forecast, by Service (2017-2030)

12.4.9.4.      Market Revenue and Forecast, by Application (2017-2030)

12.4.9.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.5.        Latin America

12.5.1.  Market Revenue and Forecast, by Type (2017-2030)

12.5.2.  Market Revenue and Forecast, by Technology (2017-2030)

12.5.3.  Market Revenue and Forecast, by Service (2017-2030)

12.5.4.  Market Revenue and Forecast, by Application (2017-2030)

12.5.5.  Market Revenue and Forecast, by End-use (2017-2030)

12.5.6.  Brazil

12.5.6.1.      Market Revenue and Forecast, by Type (2017-2030)

12.5.6.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3.      Market Revenue and Forecast, by Service (2017-2030)

12.5.6.4.      Market Revenue and Forecast, by Application (2017-2030)

12.5.6.5.      Market Revenue and Forecast, by End-use (2017-2030)

12.5.7.  Rest of LATAM

12.5.7.1.      Market Revenue and Forecast, by Type (2017-2030)

12.5.7.2.      Market Revenue and Forecast, by Technology (2017-2030)

12.5.7.3.      Market Revenue and Forecast, by Service (2017-2030)

12.5.7.4.      Market Revenue and Forecast, by Application (2017-2030)

12.5.7.5.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 13.  Company Profiles

13.1.              Charles River Laboratories International, Inc.

13.1.1.  Company Overview

13.1.2.  Product Offerings

13.1.3.  Financial Performance

13.1.4.  Recent Initiatives

13.2.              The Jackson Laboratory

13.2.1.  Company Overview

13.2.2.  Product Offerings

13.2.3.  Financial Performance

13.2.4.  Recent Initiatives

13.3.              Laboratory Corporation of America Holdings (Covance)

13.3.1.  Company Overview

13.3.2.  Product Offerings

13.3.3.  Financial Performance

13.3.4.  Recent Initiatives

13.4.              Perkin Elmer (Horizon Discovery Group plc)

13.4.1.  Company Overview

13.4.2.  Product Offerings

13.4.3.  Financial Performance

13.4.4.  Recent Initiatives

13.5.              genOway

13.5.1.  Company Overview

13.5.2.  Product Offerings

13.5.3.  Financial Performance

13.5.4.  Recent Initiatives

13.6.              Envigo

13.6.1.  Company Overview

13.6.2.  Product Offerings

13.6.3.  Financial Performance

13.6.4.  Recent Initiatives

13.7.              JANVIER LABS

13.7.1.  Company Overview

13.7.2.  Product Offerings

13.7.3.  Financial Performance

13.7.4.  Recent Initiatives

13.8.              Taconic Biosciences, Inc.

13.8.1.  Company Overview

13.8.2.  Product Offerings

13.8.3.  Financial Performance

13.8.4.  Recent Initiatives

13.9.              Biomedical Research Models (Biomere)

13.9.1.  Company Overview

13.9.2.  Product Offerings

13.9.3.  Financial Performance

13.9.4.  Recent Initiatives

13.10.           Transpogen Biopharmaceutical, Inc.

13.10.1.               Company Overview

13.10.2.               Product Offerings

13.10.3.               Financial Performance

13.10.4.               Recent Initiatives

Chapter 14.  Research Methodology

14.1.              Primary Research

14.2.              Secondary Research

14.3.              Assumptions

Chapter 15.  Appendix

15.1.              About Us

15.2.              Glossary of Terms